Table 1 Results of previous studies on risk factors for underestimation
Variablesa,b | Significance of potential risk factors, as described in literaturec,d | ||
|---|---|---|---|
No | Yes, univariablee | Yes, multivariablef | |
Age | 15, 16, 18, 22, 24, 25 | 14, 21 | |
Detection modeg | 14, 16 | ||
Palpable | 22 | 16 | 15, 18, 23/28, 24, 25, 26 |
Clinical size of mass | 18 | ||
BI-RADS g | 21, 23 | 14, 15, 16 | |
Maximum size on imaging | 16 | 22 | |
Maximum size on mammographyg | 18, 21, 26 | 14, 20, 24, 25 | |
Maximum size on ultrasonographyg | 23 | 15, 30 | |
Maximum size on MRI | 26 | 30 | |
Mass on imaging | 14 | ||
Mass on mammography | 16, 26 | 18 | |
Mass on ultrasonography | 30 | 26 | 23/28 |
Visibility on ultrasonography | 16 | 24 | |
Type of mammographic abnormalityg | 14, 21, 24 | 15 | 25 |
Calcifications on mammography | 23, 26 | 30 | |
Calcifications on ultrasonography | 23/28 | ||
Suspicious findings on ultrasonography or MRI | 30 | ||
Multicentric | 14 | ||
Breast density | 14 | ||
Residual disease on mammogram after biopsy | 21 | ||
Calcification % removed by CNB | 14 | ||
Biopsy guidance techniqueg | 14, 16, 24, 26 | ||
Biopsy type CNB, VAB | 24 | 16, 25 | 15, 22, 23/28 |
Biopsy needle gauge | 14 | ||
Number of cores obtainedg | 14, 21 | 15, 25, 26 | |
DCIS grade | 26 | 16, 23, 24, 25 | 14, 15, 20 |
Nuclear grade | 26, 30 | 22 | |
Suspicious of invasion on biopsy | 23/28, 24 | ||
Comedo-necrosis | 16, 18, 23, 26 | 14, 22, 25 | 30 |
Intraductal structure | 25 | ||
Cibriform | 14 | 22 | |
Sclerosing adenosis | 30 | ||
Hormone receptor ER/PR | 22 | ||
Progesterone receptor | 30 | ||
HER2 | 22 | 30 | |